The Edinburgh Investment Trust plc is a listed investment company, whose market capitalisation is £1,136 million = £1.136 Billion
Day to day management is by Invesco Perpetual, currently managed by Neil Woodford, who shortly will depart from Invesco Perpetual.
Its top 10 holdings are:
GlaxoSmithKline 8.9% of the portfolio
AstraZeneca 8.7% of the portfolio
BT 7.8% of the portfolio
British American Tobacco 6.3% of the portfolio
Roche – Swiss common stock 6.2% of the portfolio
BAE Systems 5.6% of the portfolio
Imperial Tobacco 5.2% of the portfolio
Reckitt Benckiser 4.6% of the portfolio
Reynolds American – US common stock 4.4% of the portfolio
Capita 4.3% of the portfolio
The top 10 holdings make up 62% of the £1.136 Billion.
Looking at the total portfolio [http://www.invescoperpetual.co.uk/site/ip/pdf/The-Edinburgh-Investment-Trust-plc-portfolio-disclosure.pdf]
It only has holdings in 46 companies.
Interesting to note that the largest single holding of the Edinburgh Investment Trust, is GlaxoSmithKline.
It owns 7,733,586 shares. Today GlaxoSmithKline has a share structure of 4,862,666,685 shares.
This means that the Edinburgh Investment Trust plc owns 0.15% of GlaxoSmithKline PLC.
The yield on Edinburgh Investment Trust plc is 3.9%. Incredible yield in this low interest rate climate.